University of Sheffield Featured PhD Programmes
Newcastle University Featured PhD Programmes
University of Kent Featured PhD Programmes
Ulster University Featured PhD Programmes
University of Hull Featured PhD Programmes

screening PhD Projects, Programs & Scholarships

We have 147 screening PhD Projects, Programs & Scholarships

  • "screening" ×
  • clear all
Order by 
Showing 41 to 50 of 147
  Automated 3D-Printed Microfluidic System for Nano-Catalyst Development
  Dr K Wu, Dr J Fernandez-Garcia
Application Deadline: 2 February 2020

Funding Type

PhD Type

Catalysts are crucial for the £3,500B/year global chemical industry on which our modern civilization depends. Different catalysts are in constant development to fulfil economic, political and environmental demands.
  Identification of mlm receptor antagonists for treatment of cancer
  Dr R Foster
Applications accepted all year round

Funding Type

PhD Type

Recent high impact publications have identified antagonism of the mlm receptor as a possible target for treatment of cancer. The native ligand of the receptor has been linked to cell proliferation which has been proven to be as a result of increased nitric oxide (NO) concentration.
  Identifying novel treatment options for ovarian carcinosarcoma
  Dr H Barker
Application Deadline: 31 January 2020

Funding Type

PhD Type

Location. The Walter and Eliza Hall Institute of Medical Research, University of Melbourne. Supervisors. Prof C. Scott, Dr H. Barker.
  De Novo Mutations and Human Disease
  Prof A Goriely, Prof A Wilkie
Application Deadline: 24 July 2020

Funding Type

PhD Type

De novo mutations (DNMs) are a significant contributor to human disease, affecting ~1:300 new births. We study the mechanisms by which these spontaneous mutations arise in the first instance, concentrating on the tissue where most of them originate, the human testis.
  De Novo Mutations and Human Disease
  Prof A Goriely, Prof A Wilkie
Application Deadline: 24 July 2020

Funding Type

PhD Type

De novo mutations (DNMs) are a significant contributor to human disease, affecting ~1:300 new births. We study the mechanisms by which these spontaneous mutations arise in the first instance, concentrating on the tissue where most of them originate, the human testis.
  Identifying pharmacological targets for osteoporosis intervention using whole-genome and exome sequencing of bone related phenotypes
  Dr J Kemp
Applications accepted all year round

Funding Type

PhD Type

Osteoporosis (OP) is an often asymptomatic multi-factorial condition that is characterized by a progressive loss of bone mass resulting in increased fracture (FX) risk and reduced lifespan(1).
  Chemo-enzymatic Synthesis and Potential Applications of Novel Heterocyclic Alkaloids
  Dr H Deng, Dr L Trembleau
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is rising to dangerously high levels in all parts of the world. In Europe alone, drug-resistant bacteria are estimated to cause 25,000 deaths annually and cost more than US$1.5 billion every year in healthcare expenses and productivity losses.
  Do rural-dwellers develop more aggressive breast and prostate cancer than those living in the city?
  Prof P Murchie, Dr Z Miedzybrodzka, Prof V Speirs, Dr R Vieira
Application Deadline: 13 March 2020

Funding Type

PhD Type

BACKGROUND.
  Development of new drugs to reverse tumour resistance to chemotherapy
  Research Group: Biomedical Research Group
  Dr C Erridge, Dr G Pirianov
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (LifETIME)

Funding Type

PhD Type

The CDT will train the next generation of leaders in developing in vitro tissues, sensing and diagnostics to develop humanised in vitro systems to drive better drug screening.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.